Zhejiang Shouxiangu Pharmaceutical Co., Ltd.

SHSE:603896 Stock Report

Market Cap: CN¥4.3b

Zhejiang Shouxiangu Pharmaceutical Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Zhen-Yu Li

Chief executive officer

CN¥410.8k

Total compensation

CEO salary percentagen/a
CEO tenure2.6yrs
CEO ownershipn/a
Management average tenureno data
Board average tenure2.6yrs

Recent management updates

Recent updates

We Think That There Are More Issues For Zhejiang Shouxiangu Pharmaceutical (SHSE:603896) Than Just Sluggish Earnings

Nov 04
We Think That There Are More Issues For Zhejiang Shouxiangu Pharmaceutical (SHSE:603896) Than Just Sluggish Earnings

Weak Statutory Earnings May Not Tell The Whole Story For Zhejiang Shouxiangu Pharmaceutical (SHSE:603896)

May 02
Weak Statutory Earnings May Not Tell The Whole Story For Zhejiang Shouxiangu Pharmaceutical (SHSE:603896)

CEO

Zhen-Yu Li (33 yo)

2.6yrs

Tenure

CN¥410,800

Compensation

Mr. Zhen-Yu Li is GM & Director of Zhejiang Shouxiangu Pharmaceutical Co. Ltd. from April 22, 2022.

Board Members

NamePositionTenureCompensationOwnership
Zhen-Yu Li
GM & Director2.6yrsCN¥410.80kno data
Jing Xu
Deputy GM & Directorno dataCN¥323.90k0.31%
CN¥ 13.3m
Hangfeng Huang
Director & Deputy GMno dataCN¥407.20k0.046%
CN¥ 2.0m
Guofang Liu
Deputy GMno dataCN¥328.10k0.13%
CN¥ 5.6m
Lingjuan Hu
Supervisor2.6yrsno datano data
Junhua Huang
Employee Representative Supervisor1.5yrsno datano data

2.6yrs

Average Tenure

39yo

Average Age

Experienced Board: 603896's board of directors are not considered experienced ( 2.6 years average tenure), which suggests a new board.